ZA92155B - Tetrazole derivatives,process for their preparation and their use - Google Patents

Tetrazole derivatives,process for their preparation and their use

Info

Publication number
ZA92155B
ZA92155B ZA92155A ZA92155A ZA92155B ZA 92155 B ZA92155 B ZA 92155B ZA 92155 A ZA92155 A ZA 92155A ZA 92155 A ZA92155 A ZA 92155A ZA 92155 B ZA92155 B ZA 92155B
Authority
ZA
South Africa
Prior art keywords
preparation
tetrazole derivatives
denotes
tetrazole
derivatives
Prior art date
Application number
ZA92155A
Other languages
English (en)
Inventor
Dieter Binder
Binder Dieter
Josef Weinberger
Weinberger Josef
Andreas Koch
Koch Andreas
Original Assignee
Chem Pharm Forsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Pharm Forsch Gmbh filed Critical Chem Pharm Forsch Gmbh
Publication of ZA92155B publication Critical patent/ZA92155B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Reinforced Plastic Materials (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
ZA92155A 1991-01-31 1992-01-09 Tetrazole derivatives,process for their preparation and their use ZA92155B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0020991A AT395853B (de) 1991-01-31 1991-01-31 Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
ZA92155B true ZA92155B (en) 1992-10-28

Family

ID=3484393

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92155A ZA92155B (en) 1991-01-31 1992-01-09 Tetrazole derivatives,process for their preparation and their use

Country Status (27)

Country Link
US (1) US5254574A (no)
EP (1) EP0497121B1 (no)
JP (1) JPH0641099A (no)
KR (1) KR920014802A (no)
CN (1) CN1034662C (no)
AT (2) AT395853B (no)
AU (1) AU642575B2 (no)
CA (1) CA2060387A1 (no)
CZ (1) CZ27592A3 (no)
DE (1) DE59208058D1 (no)
DK (1) DK0497121T3 (no)
EG (1) EG19886A (no)
ES (1) ES2100242T3 (no)
FI (1) FI920349A (no)
GR (1) GR3022686T3 (no)
HU (1) HUT62583A (no)
IE (1) IE914501A1 (no)
IL (1) IL100621A (no)
LT (1) LTIP1518A (no)
LV (1) LV10446B (no)
MY (1) MY106314A (no)
NO (1) NO179837C (no)
NZ (1) NZ241293A (no)
RU (1) RU2078764C1 (no)
SI (1) SI9210026A (no)
YU (1) YU48089B (no)
ZA (1) ZA92155B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255802B (it) * 1992-08-07 1995-11-16 Luso Farmaco Inst Derivati imidazolici ad attivita' a ii antagonista
GB9507203D0 (en) * 1995-04-07 1995-05-31 Smithkline Beecham Plc Novel compounds
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
DE602004029373D1 (de) * 2003-08-27 2010-11-11 Zentiva Ks Verfahren zur entfernung der triphenylmethanschutzgruppe
US7803940B2 (en) * 2006-11-24 2010-09-28 Takeda Pharmaceutical Company Limited Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2930674A1 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (ja) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9930928B2 (en) 2013-02-13 2018-04-03 Adidas Ag Sole for a shoe
DE102013202306B4 (de) 2013-02-13 2014-12-18 Adidas Ag Sohle für einen Schuh
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
USD776410S1 (en) 2013-04-12 2017-01-17 Adidas Ag Shoe
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
USD783264S1 (en) 2015-09-15 2017-04-11 Adidas Ag Shoe

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860691D1 (en) * 1977-07-12 1981-08-13 Synthelabo 1,2,4-oxadiazol derivatives, their preparation and application in pharmaceutical compositions
US4771051A (en) * 1985-05-17 1988-09-13 A/S Ferrosan 3-substituted-4,5-dihydro-5-oxo imidazoquinazolines, their preparation, and their use in treating benzodiazepin receptor-related ailments
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
DE3627155A1 (de) * 1986-08-11 1988-02-18 Schering Ag Imidazol-derivate
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
WO1991000277A1 (en) * 1989-06-30 1991-01-10 E.I. Du Pont De Nemours And Company Substituted imidazoles

Also Published As

Publication number Publication date
ATE149164T1 (de) 1997-03-15
CN1063689A (zh) 1992-08-19
AT395853B (de) 1993-03-25
LTIP1518A (en) 1995-06-26
ATA20991A (de) 1992-08-15
CN1034662C (zh) 1997-04-23
US5254574A (en) 1993-10-19
YU48089B (sh) 1997-01-08
FI920349A0 (fi) 1992-01-27
JPH0641099A (ja) 1994-02-15
RU2078764C1 (ru) 1997-05-10
MY106314A (en) 1995-04-29
SI9210026A (en) 1994-09-30
IL100621A (en) 1996-08-04
EP0497121B1 (de) 1997-02-26
IE914501A1 (en) 1992-07-29
IL100621A0 (en) 1992-09-06
CA2060387A1 (en) 1992-08-01
AU1063492A (en) 1992-08-06
FI920349A (fi) 1992-08-01
GR3022686T3 (en) 1997-05-31
HUT62583A (en) 1993-05-28
YU2692A (sh) 1994-11-15
NO920122L (no) 1992-08-03
AU642575B2 (en) 1993-10-21
NO179837B (no) 1996-09-16
CZ27592A3 (en) 1993-03-17
NZ241293A (en) 1993-04-28
KR920014802A (ko) 1992-08-25
LV10446A (lv) 1995-02-20
LV10446B (en) 1995-10-20
ES2100242T3 (es) 1997-06-16
NO920122D0 (no) 1992-01-09
DE59208058D1 (de) 1997-04-03
DK0497121T3 (da) 1997-05-05
EP0497121A1 (de) 1992-08-05
EG19886A (en) 1996-05-31
HU9200292D0 (en) 1992-04-28
NO179837C (no) 1996-12-27

Similar Documents

Publication Publication Date Title
EG19886A (en) Process for the preparation of new tetrazole derivatives and their use
CA2030338A1 (fr) Composition reductrice, pour deformation permanente des cheveux, contenant en tant qu'agent reducteur un amino mercaptoalkylamide ou l'un de ses sels, et son utilisation dans un procede de deformation permanente des cheveux
IT1255729B (it) Derivati di s-triazina come agenti fotostabilizzanti
AU534233B2 (en) Muramyldipeptide derivatives
IL90309A0 (en) 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidinedione derivatives,their preparation and their application in therapy
YU86792A (sh) Rastvor sparfloksacina, njegovo dobijanje i so sparfloksacina kao komponenta rastvora
IL69683A0 (en) Isoquinoline derivatives,a process for their preparation,pharmaceutical formulations based on these compounds and the use thereof
ES2104509A1 (es) Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
AU641686B2 (en) Benzanilides
GR81837B (no)
PT90262A (pt) Processo para a preparacao de novos derivados trienicos com estrutura cromenica
GB2282810A (en) Process for the preparation of clavulanic acid
ZA828237B (en) A vasodilator compound,process for the preparation thereof and pharmaceutical compositions therefrom
GB2001054A (en) Inhibitors for body fluid proteins
IT1245631B (it) Impiego di composti macrolidi come agenti anti-infiammatori per il trattamento di malattie provocate da cessione di istamina
IT1273591B (it) Composti lattonici utili per il trattamento dell'osteoporosi
IT1252569B (it) Derivati di tetraidro-5-isochinolinsolfonammidi
IT1255093B (it) Derivati imidazolidinonici come agenti nootropici